Your biomarker moved. What actually changed?
A practical distinction between a measured response and a meaningful benefit.
Before celebrating a change in a biological number, ask what that number was qualified to tell you.
Three different questions
Did the intervention change the measured signal? Did it change the process we care about? Did that change improve an outcome that matters to people? Those questions are connected, but they are not interchangeable.
The same discipline applies to skin science
An irritation assay, a mechanistic experiment and a consumer efficacy study answer different questions. Keep the claim within the boundaries of the experiment. A favorable laboratory result is not a general certificate of safety, effectiveness or rejuvenation.
A useful evidence note
Record the population or model, intervention, comparator, endpoint, uncertainty and intended decision. State what the finding does not establish with the same care as what it does.
A better instrument is valuable. Knowing its limits is part of using it well.
Evidence behind this piece
A biomarker needs a clearly defined job
US Food and Drug Administration · Source date not stated
A promising signal is not the same as a proven benefit
US Food and Drug Administration · Dec 21, 2017
What a proteomic aging clock can tell us
Nature Medicine · Aug 8, 2024
Skin science offers a practical example of fit-for-purpose NAMs
OECD · Jun 25, 2025